WDR5 WIN site inhibitor C6
CAS No.
WDR5 WIN site inhibitor C6 ( —— )
Catalog No. M17068 CAS No.
WDR5 WIN site inhibitor C6 is a potent, specific WIN (WDR5 interaction) site inhibitor of WDR5 with Kd of 0.1 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
100MG | Get Quote | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameWDR5 WIN site inhibitor C6
-
NoteResearch use only, not for human use.
-
Brief DescriptionWDR5 WIN site inhibitor C6 is a potent, specific WIN (WDR5 interaction) site inhibitor of WDR5 with Kd of 0.1 nM.
-
DescriptionWDR5 WIN site inhibitor C6 is a potent, specific WIN (WDR5 interaction) site inhibitor of WDR5 with Kd of 0.1 nM; inhibits leukemia cell lines in vitro (MV4:11 cell GI50=3.2 uM), rapidly displace WDR5 from chromatin and decrease the expression of associated genes, causing translational inhibition, nucleolar stress, and p53 induction.
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetHMTase
-
RecptorHMTase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number--
-
Formula Weight498.38
-
Molecular FormulaC25H22Cl2FN5O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical NameN-(3,4-dichlorobenzyl)-3-(6-fluoro-2-methylpyridin-3-yl)-5-((2-imino-3-methyl-2,3-dihydro-1H-imidazol-1-yl)methyl)benzamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Aho ER, et al. Cell Rep. 2019 Mar 12;26(11):2916-2928.e13.
molnova catalog
related products
-
BIX-01294
A specific small molecule G9a histone methyltransferase inhibitor with IC50 of 1.7 uM.
-
NV03
NV03 is a small-molecule antagonist of the H3K9me3 binding to UHRF1 tandem tudor domain with Kd of 2.4 uM.
-
EPZ-030456
EPZ-030456 (EPZ030456) is a potent, selective SMYD3 inhibitor with biochem IC50 of 4 nM.